Search

Your search keyword '"González-Gay, Miguel Á"' showing total 420 results

Search Constraints

Start Over You searched for: Author "González-Gay, Miguel Á" Remove constraint Author: "González-Gay, Miguel Á"
420 results on '"González-Gay, Miguel Á"'

Search Results

1. Genetics of vasculitis

2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

3. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

4. Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs

8. Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients

9. Systemic treatment in sarcoidosis: Experience over two decades

10. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

11. Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients

12. Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit

13. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

14. Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients

15. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review

20. Cutaneous Vasculitis

24. HLA association with the susceptibility to anti-synthetase syndrome

25. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients

26. Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients

30. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease.

31. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease.

33. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association

34. Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients

35. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus

36. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

37. Giant Cell Arteritis

39. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study

41. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

45. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

46. Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study

48. Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis.

49. Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis.

Catalog

Books, media, physical & digital resources